What a weekend at #AHA24! Thank you to everyone who joined us for thought-provoking discussions and engaging sessions to hear more about our work in studying #genetherapy in #heart failure. We look forward to returning to Chicago for #ACC25 in the spring. #GeneTherapy #HeartFailure #CHF #ClinicalTrials
Asklepios BioPharmaceutical, Inc. (AskBio)
生物技术研究
Research Triangle Park，North Carolina 37,126 位关注者
Pioneering science to create transformative molecular medicines.
关于我们
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington’s disease, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10?, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. Vision - Pioneering science to create transformative molecular medicines. Mission - Lead innovative science and drive clinical outcomes to transform people's lives. Values: ? Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need. ? Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view. ? Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers. ? Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action. ? Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.
- 网站
-
https://www.askbio.com
Asklepios BioPharmaceutical, Inc. (AskBio)的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Research Triangle Park，North Carolina
- 类型
- 私人持股
- 创立
- 2001
- 领域
- AAV、Adeno-Associated Virus、Gene Therapy、Rare Disease、AAV Manufacturing、Molecular Medicine、Nucleic Acid、Epigenome和Doggybone DNA
地点
Asklepios BioPharmaceutical, Inc. (AskBio)员工
-
Gustavo Pesquin
-
Doug Schantz
Senior Vice President of Clinical Operations at Asklepios BioPharmaceutical, Inc. (AskBio)
-
Kira Mour?o MBCS
Principal Machine Learning Scientist at Asklepios BioPharmaceutical, Inc. - (AskBio)
-
Kara Witcoff
Patient Advocacy & External Engagement / Public Affairs / Strategic Alliances / Business Development / Global Relations
动态
-
Thank you to the #AskBio Asian American and Pacific Islander Employee Resource Group for organizing this year's internal Diwali celebration. Employees enjoyed lunch and discussing the historical meaning of the global festival of lights that is celebrated by approximately a billion people across the world. We are proud of the cultural diversity at AskBio and believe it contributes to providing an environment for our employees to reach their fullest potential. #Leadership #Diwali #Diversity
-
Today, the #AskBio team was?excited?to welcome?Sebastian Guth,?Chief Operating Officer, Bayer | Pharmaceuticals, and President of Bayer US,?and his leadership team to our Research Triangle Park, NC, headquarters. Leaders from both teams engaged throughout the day to go deeper on the work AskBio is leading to advance gene therapy and outcomes for patients, families, and caregivers. Together, we can lead innovative science and drive clinical outcomes to transform people's lives.?#TeamBayer Gustavo Pesquin, Tracy Dowling, Ralph Herbst, Canwen Jiang, Melissa Murrell, Mansuo L Shannon, Meg Heim, Anand Mirchandani, Victor Stukat Gren, Sebastian Guth, Simon Rosof, Jennifer Restivo, Sara Hegab, MD, Guru Ramamurthy, Sue Ann Pentecost, Milton Bogus, Peter Lührs, Nick Lucente, Claudia Ciciliano, Lothar Roessig, MD, Adrian Kells, Stephan Mittermeyer, PhD, Steven Elmes, Santosh Sanganalmath MD, PhD, FACC, Pooja Merchant, Doug Danison, Vinay Ramabhadran, PhD, Michael Bolon, PhD
-
-
November is National Family Caregiver's Month?in the U.S., a time to celebrate and support the millions of caregivers who embrace their responsibility to care for their loved ones.?The commitment caregivers have is unparalleled,?as caregiving can often be a full-time role.?We have been fortunate to learn from so many caregivers and would like to thank them for helping us raise awareness about limb-girdle muscular dystrophy (LGMD), Pompe disease, Parkinson's disease, multiple system atrophy (MSA), and others.?? ? At #AskBio, we are humbled by the enormity of our mission?and the work we do each day to?advance science and clinical outcomes for patients, families, and caregivers. Together, we can lead innovative science and drive clinical outcomes to transform people's lives.?? ? #NFCMonth #Caregiving #ParkinsonsDisease #LGMD #PompeDisease #MultipleSystemAtrophy
-
Don’t forget to visit the AskBio at Booth #2132 on the final day of #AHA24! Saturday, we had the privilege of hosting an inspiring Learning Studio session and an engaging Cardio Talk. Today is your last chance to connect with our team and explore how we’re working toward advancing the potential of #genetherapy. We’re excited to share our vision and hear your thoughts—stop by our booth to meet the team! #HeartFailure #HCF #ClinicalTrials
-
We’re live at #AHA24! Stop by booth #2312 to learn more about our work in advancing #hearthealth. Our team looks forward to connecting with you! American Heart Association #GeneTherapy #HeartFailure #CHF #ClinicalTrials
-
-
At #AskBio our commitment to embracing responsibility begins with advancing science and clinical outcomes for our patients, families, and caregivers. Yet our responsibility extends beyond the science to support the communities we serve through active participation in local events.? ? We are proud to have recently sponsored the 2024 Philadelphia Heart Walk to raise funds in support of the American Heart Association.? ? In RTP, we also sponsored the Parkinson's Moving Day NC Triangle event to raise funds to support families affected by Parkinson's disease.? ? #Leadership #Parkinsons
-
The #AskBio team is gearing up for an action-packed weekend at #AHA24! Visit us at Booth #2312 or join us for lunch at the HEARTHub Learning Center to learn more about AAV #GeneTherapy for #cardiovascularhealth and to hear the latest on our GenePHIT investigational clinical trial. We have a full lineup designed to advance cardiovascular knowledge. Save your seat: ?https://bit.ly/4hxxbXS. #HeartFailure #CHF #ClinicalTrials
-
Meet our HEARTHub Learning Studio speakers for the American Heart Association’s annual #AHA24 conference. Their insights will help to reshape how we aim to target #cardiovasculardisease through AAV #genetherapy. Don’t miss out – join us on November 16. Save your seat and join us for a lunch and learn: https://bit.ly/4hxxbXS. #HeartFailure #CHF #ClinicalTrials
-
Thanks to Tracy Dowling for her part in helping biotech and pharma colleagues learn more about the state of the cell and gene therapy industry during today's engaging, standing room only panel discussion at Advanced Therapies USA 2024. We were particularly happy to have the opportunity to share more about #AskBio’s commitment to exploring the potential of gene therapy beyond rare diseases. Our company prioritizes programs in areas of significant unmet need, as we believe these are the areas where we can make the most meaningful difference for patients. #ParkinsonsDisease and #CongestiveHeartFailure are two of these. #Leadership
It was exciting to represent #AskBio earlier today at Advanced Therapies USA 2024 in Philadelphia, where I had the opportunity to discuss the state of the cell and gene therapy industry with Sven Kili, Chris Stevens, Nan Zhang, Steven Kelly, Kinnari Patel, PharmD, MBA, and Dan Kirby.? ? Our industry is in the middle of an amazing moment, particularly in #GeneTherapy, where innovative approaches designed to address some of today’s most significant unmet medical needs have resulted in recent regulatory approvals and the advancement of clinical trials in rare and, for AskBio, more common diseases such as Parkinson’s and congestive heart failure. Our discussion covered this and other important topics from a variety of perspectives.
-